Also we have an important paper from Heo et al. showing the usefulness of combining both ASPECTS and CT angiography collateral score to predict outcome in acute ischemic stroke. Importantly, Ang et al. have shown that it is not necessary to wait for serum creatinine to do this using multimodal CT as only minor transient changes in renal function occur with no lasting sequelae.
We also have an interesting article from Giruparajah et al., reporting the results of a global survey -Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke; there seems to be little appetite for the use of transesopheagal echocardiography or prolonged cardiac monitoring in these cases and the standard therapy is an antiplatelet agent; clearly this sets the scene for trials of therapy which are ongoing involving the new oral anticoagulants.
Finally, we have a thoughtful contribution from Peter Sandercock on the issue of personalised medicine in stroke, as he highlights, we have enough to do implementing the evidencebased therapies we already have available; refining their use to individuals remains a laudable aim and should be the subject of research for years to come.
